Litcius/Paper detail

Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders

Ambra Del Grosso, Gabriele Parlanti, Roberta Mezzena, Marco Cecchini

2022Advanced Drug Delivery Reviews38 citationsDOI

Topics & Concepts

Enzyme replacement therapyMedicineFabry diseaseSubstrate reduction therapyLysosomal storage disordersDiseaseNeurosciencePathologyBiologyLysosomal Storage Disorders ResearchBiomedical Research and PathophysiologyCellular transport and secretion
Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders | Litcius